Form 4: Novavax Director Gregg H. Alton Reports Changes in Beneficial Ownership

Director Gregg H. Alton reports multiple transactions involving Novavax Inc. common stock throughout 2024, resulting in an increased direct ownership.

Summary

• Gregg H. Alton, a director of Novavax Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
• The report covers transactions from March 31, 2024, to December 31, 2024.
• Alton acquired shares of common stock in multiple transactions at varying prices: 3,420 shares at $4.9 on March 31, 2024, 1,202 shares at $13.93 on June 30, 2024, 1,311 shares at $12.77 on September 30, 2024 and 1,982 shares at $8.61 on December 31, 2024.
• Alton also disposed of 3,420 shares on March 31, 2024.
• Following these transactions, Alton directly owns 18,385 shares of Novavax common stock as of December 31, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director is increasing their holdings, which could indicate confidence, but it's a routine filing.

Positives

• The director's continued investment in Novavax stock could be interpreted as a positive signal about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's sentiment and confidence in the company's future performance.

Stakeholder Impact

• Shareholders may view the director's increased stock ownership as a positive sign.

Key Dates

Keywords

Form 4, Beneficial Ownership, NVAX, Novavax, Director, Alton, Stock Transactions